Marco Alpegiani

This inventor holds 41 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Farmitalia Carlo Erba, Farmitalia Carlo Erba S.r.l., Olon S.p.a.. Active years: 1982-2018.

USPTO Granted Patents = 41 (Patent Applications = 1)

% Patents Active = 87.8

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 8)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 132(Granted Patents)

Location History:

Caminata Val Tidone, IT (1982)
Milan, IT (1985 - 2016)
Rodano, IT (2010 - 2018)
Rodano (MI), IT (2018)

Company Filing History:

12 out of 208

Farmitalia Carlo Erba

patents

11 out of 140

Farmitalia Carlo Erba S.r.l.

Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.

patents

7. 1 out of 72

Basilea Pharmaceutica Ag

patents

8. 1 out of 220

Pharmacia Corporation

patents

Years Active: 1982-2018

Loading Chart...

Areas of Expertise:

Enzalutamide

Cefdinir Salts

Penem Derivatives

Abiraterone Acetate

Matrix Metalloproteinase Inhibitors

Camptothecin

Crystalline Salts

Stereoselective Processes

Anti-Metastatic Agents

Beta-Lactam Derivatives

Acyloxycephem Derivatives

Tricyclic Cefem Sulphones

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10035776 - Process for the preparation of enzalutamide (2018-07-31),

2. 9975832 - Process for the preparation of ospemifene and fispemifene (2018-05-22),

3. 9630987 - Procedure for the preparation of abiraterone acetate and intermediates thereof (2017-04-25),

4. 9556219 - Procedure for the preparation of abiraterone acetate and intermediates thereof (2017-01-31),

5. 9447109 - Crystalline salts of asenapine (2016-09-20),

6. 9340571 - Process for the purification of abiraterone acetate (2016-05-17),

7. 9315541 - Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives (2016-04-19),

8. 8865697 - Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1'-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use (2014-10-21),

9. 8247426 - Crystalline irinotecan hydrochloride and methods for its preparation (2012-08-21),

10. 8124769 - Stereoselective process and crystalline forms of a camptothecin (2012-02-28),

11. 8101758 - Stereoselective process and crystalline forms of a camptothecin (2012-01-24),

12. 7799921 - Stereoselective process and crystalline forms of a camptothecin (2010-09-21),

13. 7405294 - Intermediate cefdinir salts (2008-07-29),

14. 7173126 - Crystalline cefdinir salts (2007-02-06),

15. 6482827 - Matrix metalloproteinase inhibitors (2002-11-19),

Title: Inventor Marco Alpegiani: Revolutionizing Technology in Rodano

Introduction: Marco Alpegiani is a visionary inventor hailing from Rodano, Italy, known for his groundbreaking contributions to the field of technology.

Latest Patents: Marco Alpegiani holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Marco Alpegiani has worked with leading tech companies to develop cutting-edge solutions that have redefined industries and improved the quality of life for many.

Collaborations: Throughout his career, Marco Alpegiani has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Marco Alpegiani's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field, with a lasting impact on the world of inventions and patents.